Sign In or Subscribe

Get Full access to Top 1000 data, subscribe from only €29

Register Now »

Biomarin

Add to comparison

BioMarin develops and commercialises innovative biopharmaceuticals for rare diseases driven by genetic causes.

Financial Data

31st Dec 18 Source: CRO
- €1.1 billion turnover
- €43 million profit
- 385 employees
- Auditor: KPMG
- Audit Fees: Purchase access »
- Non-Audit Fees: Purchase access »
- Tax On Profit: Purchase access »
31st Dec 17 Source: CRO
- €491.6 million turnover
- €1 million profit
- 300 employees
- Auditor: KPMG
- Audit Fees: Purchase access »
- Non-Audit Fees: Purchase access »
- Tax On Profit: Purchase access »
3 more years available »

Ranking

By Turnover

(€1.1 billion)

90^th in Top Companies
15^th in Health

By Employees

(385)

432^nd in Top Companies
63^rd in Health

Nearest in Top 1000

Top 5 By Industry

90^th in Top Companies

By Turnover

Employees: 385
Turnover: €1.1 billion

Employees

Michael O’Donnell CEO/Managing Director

Latest News

Newsletter